Ifrah Financial Services, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1382646 Little Rock, AR

Position in VRTX

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$1,518,006

+$54,695 QoQ

Shares Held

3,056

-6.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.53%

of 13F equity value

Holder Rank

#745

of 1,735 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Ifrah Financial Services, Inc. holds $2,383,535 across 3 Biotechnology names. VRTX ranks #1 (63.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	3,056	$1,518,006
2	HALO	Halozyme Therapeutics, Inc.	6,974	$545,854
3	INCY	Incyte Corp	2,820	$319,675

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,518,006	3,056	-6.7%	Shares	Sole	2026-07-21
2026-03-31	$1,463,311	3,277	-3.5%	Shares	Sole	2026-04-22
2025-12-31	$1,540,063	3,397	-2.3%	Shares	Sole	2026-01-22
2025-09-30	$1,361,340	3,476	-0.7%	Shares	Sole	2025-10-22
2025-06-30	$1,558,645	3,501	-1.2%	Shares	Sole	2025-07-29
2025-03-31	$1,718,686	3,545	-7.2%	Shares	Sole	2025-04-29
2024-12-31	$1,537,508	3,818	-3.3%	Shares	Sole	2025-01-31
2024-09-30	$1,837,066	3,950	-2.5%	Shares	Sole	2024-10-31
2024-06-30	$1,899,253	4,052	-9.0%	Shares	Sole	2024-08-05
2024-03-31	$1,862,234	4,455	-2.2%	Shares	Sole	2024-05-06
2023-12-31	$1,854,197	4,557	-3.8%	Shares	Sole	2024-02-06
2023-09-30	$1,646,896	4,736	-1.0%	Shares	Sole	2023-11-06
2023-06-30	$1,683,889	4,785	-1.6%	Shares	Sole	2023-08-01
2023-03-31	$1,531,555	4,861	-2.4%	Shares	Sole	2023-05-05
2022-12-31	$1,438,124	4,980	-3.2%	Shares	Sole	2023-02-06
2022-09-30	$1,489,683	5,145	-0.7%	Shares	Sole	2022-11-07
2022-06-30	$1,460,517	5,183	-1.6%	Shares	Sole	2022-08-05
2022-03-31	$1,374,007	5,265	+101.4%	Shares	Sole	2022-05-03
2021-12-31	$574,034	2,614	—	Shares	Sole	2022-02-01
No filing history on record for this holder in this stock.